{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T03:42:48Z","timestamp":1771904568499,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Swiss Government Excellence Scholarship"},{"name":"CRPP \u201cAI Oncological Imaging Network\u201d"},{"name":"Palatin fundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study aimed to evaluate the diagnostic accuracy of Node Reporting and Data System (Node-RADS) in discriminating between normal, reactive, and metastatic axillary LNs in patients with melanoma who underwent SARS-CoV-2 vaccination. Patients with proven melanoma who underwent a 2-[<jats:sup>18<\/jats:sup>F]-fluoro-2-deoxy-D-glucose positron emission tomography\/computed tomography (2-[<jats:sup>18<\/jats:sup>F]-FDG PET\/CT) between February and April 2021 were included in this retrospective study. Primary melanoma site, vaccination status, injection site, and 2-[<jats:sup>18<\/jats:sup>F]-FDG PET\/CT were used to classify axillary LNs into normal, inflammatory, and metastatic (combined classification). An adapted Node-RADS classification (A-Node-RADS) was generated based on LN anatomical characteristics on low-dose CT images and compared to the combined classification. 108 patients were included in the study (54 vaccinated). HALNs were detected in 42 patients (32.8%), of whom 97.6% were vaccinated. 172 LNs were classified as normal, 30 as inflammatory, and 14 as metastatic using the combined classification. 152, 22, 29, 12, and 1 LNs were classified A-Node-RADS 1, 2, 3, 4, and\u00a05, respectively. Hence, 174, 29, and 13 LNs were deemed benign, equivocal, and metastatic. The concordance between the classifications was very good (Cohen\u2019s <jats:italic>k<\/jats:italic>: 0.91, CI 0.86\u20130.95; <jats:italic>p<\/jats:italic>-value\u2009&lt;\u20090.0001). A-Node-RADS can assist the classification of axillary LNs in melanoma patients who underwent 2-[<jats:sup>18<\/jats:sup>F]-FDG PET\/CT and SARS-CoV-2 vaccination.<\/jats:p>","DOI":"10.1038\/s41598-023-44215-2","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T12:02:13Z","timestamp":1698321733000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Characterization of hypermetabolic lymph nodes after SARS-CoV-2 vaccination using PET-CT derived node-RADS, in patients with melanoma"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2224-0083","authenticated-orcid":false,"given":"Antonio G.","family":"Gennari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6845-1199","authenticated-orcid":false,"given":"Alexia","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4812-987X","authenticated-orcid":false,"given":"Thomas","family":"Sartoretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6964-802X","authenticated-orcid":false,"given":"Alexander","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2721-9726","authenticated-orcid":false,"given":"Stephan","family":"Skawran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4584-3031","authenticated-orcid":false,"given":"Valerie","family":"Treyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Sartoretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5778-5270","authenticated-orcid":false,"given":"Alessandra","family":"Curioni-Fontecedro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9095-032X","authenticated-orcid":false,"given":"Moritz","family":"Schwyzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4175-0476","authenticated-orcid":false,"given":"Stephan","family":"Waelti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4849-3292","authenticated-orcid":false,"given":"Martin W.","family":"Huellner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2549-4559","authenticated-orcid":false,"given":"Michael","family":"Messerli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,26]]},"reference":[{"key":"44215_CR1","unstructured":"COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU) (2021)."},{"key":"44215_CR2","doi-asserted-by":"publisher","unstructured":"Sadoff, J. et al. Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMoa2101544 (2021).","DOI":"10.1056\/NEJMoa2101544"},{"key":"44215_CR3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 384, 403\u2013416. https:\/\/doi.org\/10.1056\/NEJMoa2035389 (2021).","journal-title":"N. Engl. J. Med."},{"key":"44215_CR4","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 383, 2603\u20132615. https:\/\/doi.org\/10.1056\/NEJMoa2034577 (2020).","journal-title":"N. Engl. J. Med."},{"key":"44215_CR5","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.21.25651","author":"S Mortazavi","year":"2021","unstructured":"Mortazavi, S. Coronavirus disease (COVID-19) vaccination associated axillary adenopathy: Imaging findings and follow-up recommendations in 23 women. AJR Am. J. Roentgenol. https:\/\/doi.org\/10.2214\/AJR.21.25651 (2021).","journal-title":"AJR Am. J. Roentgenol."},{"key":"44215_CR6","doi-asserted-by":"publisher","unstructured":"Ozutemiz, C. et al. Lymphadenopathy in COVID-19 vaccine recipients: Diagnostic dilemma in oncology patients. Radiology, 210275. https:\/\/doi.org\/10.1148\/radiol.2021210275 (2021).","DOI":"10.1148\/radiol.2021210275"},{"key":"44215_CR7","doi-asserted-by":"publisher","first-page":"20210084","DOI":"10.1259\/bjro.20210084","volume":"4","author":"A Maurer","year":"2022","unstructured":"Maurer, A. et al. Frequency and intensity of [(18)F]-PSMA-1007 uptake after COVID-19 vaccination in clinical PET. BJR Open 4, 20210084. https:\/\/doi.org\/10.1259\/bjro.20210084 (2022).","journal-title":"BJR Open"},{"key":"44215_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-021-05314-2","author":"D Cohen","year":"2021","unstructured":"Cohen, D., Krauthammer, S. H., Wolf, I. & Even-Sapir, E. Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: Incidence assessed by [(18)F]FDG PET-CT and relevance to study interpretation. Eur. J. Nucl. Med. Mol. Imaging https:\/\/doi.org\/10.1007\/s00259-021-05314-2 (2021).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"44215_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-021-08122-2","author":"S Skawran","year":"2021","unstructured":"Skawran, S. et al. [(18)F]FDG uptake of axillary lymph nodes after COVID-19 vaccination in oncological PET\/CT: Frequency, intensity, and potential clinical impact. Eur. Radiol. https:\/\/doi.org\/10.1007\/s00330-021-08122-2 (2021).","journal-title":"Eur. Radiol."},{"key":"44215_CR10","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.2214\/AJR.21.25928","volume":"217","author":"DG Schroeder","year":"2021","unstructured":"Schroeder, D. G. et al. Frequency and characteristics of nodal and deltoid FDG and (11)C-Choline uptake on PET performed after COVID-19 vaccination. AJR Am. J. Roentgenol. 217, 1206\u20131216. https:\/\/doi.org\/10.2214\/AJR.21.25928 (2021).","journal-title":"AJR Am. J. Roentgenol."},{"key":"44215_CR11","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1097\/RLU.0000000000003800","volume":"46","author":"M Shin","year":"2021","unstructured":"Shin, M. et al. COVID-19 Vaccination-Associated Lymphadenopathy on FDG PET\/CT: Distinctive features in adenovirus-vectored vaccine. Clin. Nucl. Med. 46, 814\u2013819. https:\/\/doi.org\/10.1097\/RLU.0000000000003800 (2021).","journal-title":"Clin. Nucl. Med."},{"key":"44215_CR12","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1007\/s00259-021-05314-2","volume":"48","author":"D Cohen","year":"2021","unstructured":"Cohen, D., Krauthammer, S. H., Wolf, I. & Even-Sapir, E. Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: Incidence assessed by [(18)F]FDG PET-CT and relevance to study interpretation. Eur. J. Nucl. Med. Mol. Imaging 48, 1854\u20131863. https:\/\/doi.org\/10.1007\/s00259-021-05314-2 (2021).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"44215_CR13","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1001\/jamaoncol.2021.1794","volume":"7","author":"ME Adin","year":"2021","unstructured":"Adin, M. E., Isufi, E., Kulon, M. & Pucar, D. Association of COVID-19 mRNA vaccine with ipsilateral axillary lymph node reactivity on imaging. JAMA Oncol. 7, 1241\u20131242. https:\/\/doi.org\/10.1001\/jamaoncol.2021.1794 (2021).","journal-title":"JAMA Oncol."},{"key":"44215_CR14","doi-asserted-by":"publisher","unstructured":"Elsholtz, F. H. J. et al. Introducing the Node Reporting and Data System 1.0 (Node-RADS): a concept for standardized assessment of lymph nodes in cancer. Eur. Radiol. 31, 6116\u20136124. https:\/\/doi.org\/10.1007\/s00330-020-07572-4 (2021).","DOI":"10.1007\/s00330-020-07572-4"},{"key":"44215_CR15","doi-asserted-by":"publisher","unstructured":"Treglia, G., Cuzzocrea, M., Giovanella, L., Elzi, L. & Muoio, B. Prevalence and significance of hypermetabolic lymph nodes detected by 2-[(18)F]FDG PET\/CT after COVID-19 vaccination: A systematic review and a meta-analysis. Pharmaceuticals (Basel) 14. https:\/\/doi.org\/10.3390\/ph14080762 (2021).","DOI":"10.3390\/ph14080762"},{"key":"44215_CR16","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/d41586-021-00396-2","volume":"590","author":"N Phillips","year":"2021","unstructured":"Phillips, N. The coronavirus is here to stay\u2014here\u2019s what that means. Nature 590, 382\u2013384. https:\/\/doi.org\/10.1038\/d41586-021-00396-2 (2021).","journal-title":"Nature"},{"key":"44215_CR17","doi-asserted-by":"publisher","first-page":"20210040","DOI":"10.1259\/bjrcr.20210040","volume":"7","author":"S Shah","year":"2021","unstructured":"Shah, S., Wagner, T., Nathan, M. & Szyszko, T. COVID-19 vaccine-related lymph node activation\u2014patterns of uptake on PET-CT. BJR Case Rep. 7, 20210040. https:\/\/doi.org\/10.1259\/bjrcr.20210040 (2021).","journal-title":"BJR Case Rep."},{"key":"44215_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40644-022-00506-x","volume":"22","author":"HJ Meyer","year":"2022","unstructured":"Meyer, H. J. et al. CT texture analysis and node-RADS CT score of mediastinal lymph nodes\u2014diagnostic performance in lung cancer patients. Cancer Imaging 22, 75. https:\/\/doi.org\/10.1186\/s40644-022-00506-x (2022).","journal-title":"Cancer Imaging"},{"key":"44215_CR19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1148\/radiol.2019191326","volume":"294","author":"DM Richman","year":"2020","unstructured":"Richman, D. M. et al. Assessment of American College of radiology thyroid imaging reporting and data system (TI-RADS) for pediatric thyroid nodules. Radiology 294, 415\u2013420. https:\/\/doi.org\/10.1148\/radiol.2019191326 (2020).","journal-title":"Radiology"},{"key":"44215_CR20","doi-asserted-by":"publisher","unstructured":"Walker, S. M. et al. Prospective evaluation of PI-RADS Version 2.1 for prostate cancer detection. AJR Am. J. Roentgenol. 1\u20136. https:\/\/doi.org\/10.2214\/AJR.19.22679 (2020).","DOI":"10.2214\/AJR.19.22679"},{"key":"44215_CR21","doi-asserted-by":"publisher","unstructured":"Cagigi, A. & Lore, K. Immune responses induced by mRNA vaccination in mice, monkeys and humans. Vaccines (Basel) 9. https:\/\/doi.org\/10.3390\/vaccines9010061 (2021).","DOI":"10.3390\/vaccines9010061"},{"key":"44215_CR22","doi-asserted-by":"publisher","unstructured":"Zhou, H., Lei, P. J. & Padera, T. P. Progression of metastasis through lymphatic system. Cells 10. https:\/\/doi.org\/10.3390\/cells10030627 (2021).","DOI":"10.3390\/cells10030627"},{"key":"44215_CR23","doi-asserted-by":"publisher","unstructured":"Mao, Y., Hedgire, S. & Harisinghani, M. Radiologic assessment of lymph nodes in oncologic patients. Curr. Radiol. Rep. 2. https:\/\/doi.org\/10.1007\/s40134-013-0036-6 (2013).","DOI":"10.1007\/s40134-013-0036-6"},{"key":"44215_CR24","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1186\/s40064-016-2419-7","volume":"5","author":"G Arslan","year":"2016","unstructured":"Arslan, G., Altintoprak, K. M., Yirgin, I. K., Atasoy, M. M. & Celik, L. Diagnostic accuracy of metastatic axillary lymph nodes in breast MRI. Springerplus 5, 735. https:\/\/doi.org\/10.1186\/s40064-016-2419-7 (2016).","journal-title":"Springerplus"},{"key":"44215_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jrid.2018.01.002","volume":"5","author":"H Wang","year":"2018","unstructured":"Wang, H., Li, Q. K., Auster, M. & Gong, G. PET and CT features differentiating infectious\/inflammatory from malignant mediastinal lymphadenopathy: A correlated study with endobronchial ultrasound-guided transbronchial needle aspiration. Radiol. Infect. Dis. 5, 7\u201313. https:\/\/doi.org\/10.1016\/j.jrid.2018.01.002 (2018).","journal-title":"Radiol. Infect. Dis."},{"key":"44215_CR26","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00345-017-2135-0","volume":"36","author":"F Steinkohl","year":"2018","unstructured":"Steinkohl, F. et al. Retrospective analysis of the development of PIRADS 3 lesions over time: When is a follow-up MRI reasonable?. World J. Urol. 36, 367\u2013373. https:\/\/doi.org\/10.1007\/s00345-017-2135-0 (2018).","journal-title":"World J. Urol."},{"key":"44215_CR27","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/cen.13997","volume":"91","author":"P Trimboli","year":"2019","unstructured":"Trimboli, P. et al. A multicentre validation study for the EU-TIRADS using histological diagnosis as a gold standard. Clin. Endocrinol. (Oxf) 91, 340\u2013347. https:\/\/doi.org\/10.1111\/cen.13997 (2019).","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"44215_CR28","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.1016\/j.clbc.2018.08.011","volume":"19","author":"B Panigrahi","year":"2019","unstructured":"Panigrahi, B. et al. Characteristics and outcomes of BI-RADS 3 lesions on breast MRI. Clin. Breast Cancer 19, e152\u2013e159. https:\/\/doi.org\/10.1016\/j.clbc.2018.08.011 (2019).","journal-title":"Clin. Breast Cancer"},{"key":"44215_CR29","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.clinimag.2020.08.003","volume":"68","author":"F Agnello","year":"2020","unstructured":"Agnello, F. et al. Outcome of LR-3 and LR-4 observations without arterial phase hyperenhancement at Gd-EOB-DTPA-enhanced MRI follow-up. Clin. Imaging 68, 169\u2013174. https:\/\/doi.org\/10.1016\/j.clinimag.2020.08.003 (2020).","journal-title":"Clin. Imaging"},{"key":"44215_CR30","doi-asserted-by":"publisher","unstructured":"Leonardo, C. et al. Performance of Node-RADS scoring system for a standardized assessment of regional lymph nodes in bladder cancer patients. Cancers (Basel) 15. https:\/\/doi.org\/10.3390\/cancers15030580 (2023).","DOI":"10.3390\/cancers15030580"},{"key":"44215_CR31","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2021.20557","volume":"151","author":"C Hagen","year":"2021","unstructured":"Hagen, C. et al. Fine needle aspiration in COVID-19 vaccine-associated lymphadenopathy. Swiss Med. Wkly 151, w20557. https:\/\/doi.org\/10.4414\/smw.2021.20557 (2021).","journal-title":"Swiss Med. Wkly"},{"key":"44215_CR32","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3389\/fimmu.2019.00308","volume":"10","author":"S Schwager","year":"2019","unstructured":"Schwager, S. & Detmar, M. Inflammation and lymphatic function. Front. Immunol. 10, 308. https:\/\/doi.org\/10.3389\/fimmu.2019.00308 (2019).","journal-title":"Front. Immunol."},{"key":"44215_CR33","doi-asserted-by":"publisher","unstructured":"Smith, R. O. & Wood, W. B., Jr. Cellular mechanisms of antibacterial defense in lymph nodes; the origin and filtration effect of granulocytes in the nodal sinuses during acute bacterial lymphadenitis. J. Exp. Med. 90, 567\u2013576. doi:https:\/\/doi.org\/10.1084\/jem.90.6.567 (1949).","DOI":"10.1084\/jem.90.6.567"},{"key":"44215_CR34","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.clinimag.2014.05.003","volume":"38","author":"E Quaia","year":"2014","unstructured":"Quaia, E. et al. Predictors of mesorectal fascia invasion after gadolinium injection in rectal carcinoma after neoadjuvant therapy. Clin. Imaging 38, 698\u2013703. https:\/\/doi.org\/10.1016\/j.clinimag.2014.05.003 (2014).","journal-title":"Clin. Imaging"},{"key":"44215_CR35","doi-asserted-by":"publisher","DOI":"10.1148\/ryct.2021200563","volume":"3","author":"LV Kluner","year":"2021","unstructured":"Kluner, L. V., Oikonomou, E. K. & Antoniades, C. Assessing cardiovascular risk by using the fat attenuation index in coronary CT angiography. Radiol. Cardiothorac. Imaging 3, e200563. https:\/\/doi.org\/10.1148\/ryct.2021200563 (2021).","journal-title":"Radiol. Cardiothorac. Imaging"},{"key":"44215_CR36","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.5114\/pjr.2020.93070","volume":"85","author":"H Devos","year":"2020","unstructured":"Devos, H. et al. Fat misbehaving in the abdominal cavity: A pictorial essay. Pol. J. Radiol. 85, e32\u2013e38. https:\/\/doi.org\/10.5114\/pjr.2020.93070 (2020).","journal-title":"Pol. J. Radiol."},{"key":"44215_CR37","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.acra.2014.05.002","volume":"21","author":"E Quaia","year":"2014","unstructured":"Quaia, E. et al. Biochemical markers and MR imaging findings as predictors of crohn disease activity in patients scanned by contrast-enhanced MR enterography. Acad. Radiol. 21, 1225\u20131232. https:\/\/doi.org\/10.1016\/j.acra.2014.05.002 (2014).","journal-title":"Acad. Radiol."},{"key":"44215_CR38","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2214\/ajr.175.3.1750759","volume":"175","author":"WT Yang","year":"2000","unstructured":"Yang, W. T., Lam, W. W., Yu, M. Y., Cheung, T. H. & Metreweli, C. Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma. AJR Am. J. Roentgenol. 175, 759\u2013766. https:\/\/doi.org\/10.2214\/ajr.175.3.1750759 (2000).","journal-title":"AJR Am. J. Roentgenol."},{"key":"44215_CR39","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1017\/S0022215110001453","volume":"124","author":"RA Zoumalan","year":"2010","unstructured":"Zoumalan, R. A. et al. Lymph node central necrosis on computed tomography as predictor of extracapsular spread in metastatic head and neck squamous cell carcinoma: Pilot study. J. Laryngol. Otol. 124, 1284\u20131288. https:\/\/doi.org\/10.1017\/S0022215110001453 (2010).","journal-title":"J. Laryngol. Otol."},{"key":"44215_CR40","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1288\/00005537-199507000-00001","volume":"105","author":"DM Don","year":"1995","unstructured":"Don, D. M., Anzai, Y., Lufkin, R. B., Fu, Y. S. & Calcaterra, T. C. Evaluation of cervical lymph node metastases in squamous cell carcinoma of the head and neck. Laryngoscope 105, 669\u2013674. https:\/\/doi.org\/10.1288\/00005537-199507000-00001 (1995).","journal-title":"Laryngoscope"},{"key":"44215_CR41","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.acra.2017.10.007","volume":"25","author":"LJ Grimm","year":"2018","unstructured":"Grimm, L. J., Viradia, N. K. & Johnson, K. S. Normal axillary lymph node variability between white and black women on breast MRI. Acad. Radiol. 25, 305\u2013308. https:\/\/doi.org\/10.1016\/j.acra.2017.10.007 (2018).","journal-title":"Acad. Radiol."},{"key":"44215_CR42","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s00259-021-05652-1","volume":"49","author":"M Sollini","year":"2022","unstructured":"Sollini, M., Gelardi, F., Biroli, M. & Chiti, A. Patients\u2019 findings after COVID-19 infection and vaccinations: What to expect from [18F]FDG PET\/CT. Eur. J. Nucl. Med. Mol. Imaging 49, 791\u2013795. https:\/\/doi.org\/10.1007\/s00259-021-05652-1 (2022).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"44215_CR43","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1177\/001316447303300309","volume":"33","author":"JL Fleiss","year":"2016","unstructured":"Fleiss, J. L. & Cohen, J. The equivalence of weighted kappa and the intraclass correlation coefficient as measures of reliability. Educ. Psychol. Meas. 33, 613\u2013619. https:\/\/doi.org\/10.1177\/001316447303300309 (2016).","journal-title":"Educ. Psychol. Meas."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-44215-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-44215-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-44215-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T12:09:48Z","timestamp":1698322188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-44215-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,26]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["44215"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-44215-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,26]]},"assertion":[{"value":"18 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. A.G.G.\u2019s Ph.D. is partially supported by a personal research grant awarded by the Swiss Government Excellence Scholarship, Switzerland. Dr. A.G.G.,\u00a0Dr.\u00a0M.S., Dr. M.M., and Dr. M.W.H. are supported by a grant from the CRPP \u201cAI Oncological Imaging Network\u201d (University of Zurich). T.S.\u2019s, Dr.\u00a0M.S.\u2019s, and Dr. S.S.\u2019s work is supported by a research grant from the Palatin Foundation, Switzerland. Dr. A.R., Dr. A.M., V.T., Dr. E.S., Dr. M.S., Dr. S.W., and Dr. A.C-F. declare no potential conflict of interest. The University Hospital Zurich holds a research agreement with GE Healthcare. Neither the funders nor GE had any role in the design or execution of the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18357"}}